There are 2137 resources available
1305P - Health-related quality of life (HRQoL) in a phase III study of first-line brigatinib (BRG) vs crizotinib (CRZ) in NSCLC: Updated results from ALTA-1L
Presenter: Maria Rosario Garcia Campelo
Session: E-Poster Display
Resources:
Abstract
1306P - Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)
Presenter: Isabelle Monnet
Session: E-Poster Display
Resources:
Abstract
1307P - Blood-based genomic profiling of advanced non-small cell lung cancer (aNSCLC) patients (pts) from blood first assay screening trial (BFAST) and comparison with real-world data (RWD)
Presenter: Rafal Dziadziuszko
Session: E-Poster Display
Resources:
Abstract
1308P - Effect of current treatment evolution in advanced NSCLC on overall survival in the real world
Presenter: Aria Shokoohi
Session: E-Poster Display
Resources:
Abstract
1309P - ARC-4: Efficacy and safety of AB928 plus carboplatin, pemetrexed and a PD-1 antibody in participants with metastatic non-small cell lung cancer (mNSCLC)
Presenter: Alexander Spira
Session: E-Poster Display
Resources:
Abstract
1310P - VinMetAtezo: Phase II trial of metronomic oral vinorelbine (MOV) with atezolizumab (ATZ) for recurrent stage IV NSCLC (GFPC*04-18)**
Presenter: Alain Vergnenegre
Session: E-Poster Display
Resources:
Abstract
1311P - First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA
Presenter: Thomas John
Session: E-Poster Display
Resources:
Abstract
1312P - Chemotherapy followed by immunotherapy compared to reverse sequence in NSCLC with PD-L1 low expression: PFS2 analysis
Presenter: Marta Brambilla
Session: E-Poster Display
Resources:
Abstract
1313P - Phase III LEAP-006 safety run-in (Part 1): 1L pembrolizumab (Pembro) + chemotherapy (Chemo) with lenvatinib (Len) for metastatic NSCLC
Presenter: Makoto Nishio
Session: E-Poster Display
Resources:
Abstract
1314P - Blood-based proteomic biomarkers for predicting response to immunotherapy in non-small cell lung cancer
Presenter: Yuval Shaked
Session: E-Poster Display
Resources:
Abstract